Newsroom

DENVER--(BUSINESS WIRE)--Front Range Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for FRP-003, allowing the company to proceed with a Phase 2 clinical trial in adults with Long COVID. FDA notified the company in writing on September 30, 2026, that the study may proceed.The multicenter, randomized, double-blind, placebo-controlled Phase 2 study will enroll approximately 220 adults aged 18 to 6...

LONDON--(BUSINESS WIRE)--    DMO-TAS031/3737/002 The Minster Building 21 Mincing Lane London EC3R 7AG T 020 7862 6500 F 020 7862 6509 www.dmo.gov.uk         6 October 2026 A131\26   PRESS NOTICE   RESULT OF THE SALE BY AUCTION OF £1,250 MILLION OF 1⅛% INDEX-LINKED TREASURY GILT 2035 The United Kingdom Debt Management Office ("DMO") announces that the auction of £1,250 million of 1⅛% Index-linked Treasury Gilt 2035 (ISIN code: GB00BT7HZZ68) has been allocated as follows: (Note: all prices in thi...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...

TORONTO--(BUSINESS WIRE)--Canadian investors are navigating an increasingly complex market environment with high confidence in their portfolios. Yet new polling from PICTON Investments, conducted by Pollara Strategic Insights, suggests that confidence may not always be matched by a full understanding of the risks shaping today’s markets, or the tools available to help manage them.The survey found that 67 per cent of Canadian investors are concerned about market volatility affecting their investm...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...

FOLSOM, Calif.--(BUSINESS WIRE)--One Inc, the leading digital payments network for the insurance industry, today announced it has been named to Fintech Global’s 2026 InsurTech100, an annual list of 100 of the world’s most innovative companies providing leading solutions within InsurTech. The honor marks One Inc’s third major industry recognition in 2026, following its inclusion on CNBC’s World’s Top Fintech Companies 2026 list and the Inc. 5000 list of America’s fastest-growing private companie...

ATLANTA--(BUSINESS WIRE)--DC BLOX signs Ratepayer Protection Pledge, reinforcing commitment to fund 100% of power infrastructure and utility upgrades its data centers require....

ALBANY, N.Y.--(BUSINESS WIRE)--Acture Solutions to Acquire Digital Back Office...

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Type One Energy today announced the successful completion of a $200 million Series B financing round co-led by Breakthrough Energy Ventures and Clutterbuck Capital, with participation from Lowercarbon Capital, Siemens Energy Ventures, SiteGround Capital and other new investors. This funding supports Type One Energy’s FusionDirect™ technology development program and continued execution of Project Infinity towards the world’s first commercial fusion plant at the...

ASHBURN, Va.--(BUSINESS WIRE)--Byos Launches Embedded Edge™, an Internal Retransmission Device, with Dell Factory Integration...